1. Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents

   • Zafeiris Zafeiriou
   • Anuradha Jayaram
   • Johann S. de Bono

   Current Opinion 12 February 2016 Pages: 421 - 430

2. Pharmacotherapy for Fragile X Syndrome: Progress to Date

   • Matthew H. Davenport
   • Tori L. Schaefer
   • Craig A. Erickson

   Leading Article 08 February 2016 Pages: 431 - 445

3. Therapeutic Strategies for the Treatment of Severe Cushing’s Syndrome

   • Krystallenia I. Alexandraki
   • Ashley B. Grossman

   Therapy in Practice 01 February 2016 Pages: 447 - 458

4. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives

   • César Magro-Checa
   • Elisabeth J. Zirkzee
   • Gerda M. Steup-Beekman

   Review Article Open access 26 January 2016 Pages: 459 - 483

   

5. Liposomal Amphotericin B (AmBisome^®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

   • Neil R. H. Stone
   • Tihana Bicanic
   • William Hope

   Review Article 27 January 2016 Pages: 485 - 500

   

6. Dichlorphenamide: A Review in Primary Periodic Paralyses

   • Sarah L. Greig

   Adis Drug Evaluation 03 March 2016 Pages: 501 - 507

7. Lesinurad: First Global Approval

   • Sheridan M. Hoy

   AdisInsight Report 10 February 2016 Pages: 509 - 516

   

8. Brivaracetam: First Global Approval

   • Anthony Markham

   AdisInsight Report 22 February 2016 Pages: 517 - 522